Description based upon print version of record. GENERAL VACCINE PHARMACOLOGY

Cover -- Half Title: Fetal and Neonatal Pharmacology for the Advanced Practice??????????????? Nurse -- Author Bio -- Book Title: Fetal and Neonatal Pharmacology for the Advanced Practice Nurse -- Copyright -- Contents -- Contributors????? -- Foreword -- Preface -- Acknowledgments -- Instructor Resources -- Part 1: Basic Principles of Fetal and Neonatal Pharmacology -- Chapter 1 -- Pediatric Drug Regulation in the United States -- INTRODUCTION -- TRIAL AND ERROR: THE EVOLUTION OF REGULATORY OVERSIGHT -- OFF-PATENT MEDICATION USE -- EXPANDED PEDIATRIC DRUG LABELING: WHERE ARE WE NOW? CONCLUSIONS -- Acknowledgment -- LEARNING TOOLS AND RESOURCES -- REFERENCES -- Chapter 2: Prescriptive Authority -- APRN PRACTICE AUTHORITY -- Levels of Practice Authority and the COLLABORATIVE Practice Agreement -- Collaborative practice agreement -- CONSENSUS MODEL FOR APRN REGULATION -- APRN PRESCRIPTIVE AUTHORITY -- CONCLUSIONS -- LEARNING TOOLS AND RESOURCES -- REFERENCES -- Chapter 3: Pharmacokinetics and Pharmacodynamics -- INTRODUCTION -- PHARMACOKINETICS -- ADAPTIVE PHARMACOLOGY -- CORE PRINCIPLES OF PHARMACODYNAMICS -- CONCLUSIONS -- LEARNING TOOLS AND RESOURCES -- REFERENCES Chapter 4: Neonatal Pharmacogenomics and Pharmacogenetics -- INTRODUCTION -- DEVELOPMENTAL VARIATIONS IN PHARMACOKINETICS AND PHARMACODYNAMICS -- PHARMACOGENETICS VersuS PHARMACOGENOMICS -- PRINCIPLES AND CONCEPTS -- GENE POLYMORPHISMS AFFECTING DRUG DISPOSITION -- METHODOLOGIES -- pharmacogenomics AND NEONATAL PHARMACOLOGY -- NEONATAL PHARMACOGENOMICS: PAST, PRESENT, FUTURE -- CONCLUSIONS -- LEARNING TOOLS AND RESOURCES -- REFERENCES -- Chapter 5: Perinatal Pharmacology -- INTRODUCTION -- THE PLACENTA: SEMINAL AND OTHER NOTEWORTHY DISCOVERIES MEDICATION USE DURING PREGNANCY AND TERATOGENIC RISK -- PHYSIOLOGY REVIEW: THE INTERVILLOUS SPACE -- MATERNAL ADAPTATIONS TO PREGNANCY -- BASIC PRINCIPLES OF MATERNAL-FETAL DRUG TRANSPORT -- COMMON DISEASES THAT REQUIRE PHARMACOTHERAPIES DURING PREGNANCY -- DRUGS IN LABOR AND THE EFFECT ON THE FETUS AND NEWBORN -- CONCLUSIONS -- LEARNING TOOLS AND RESOURCES -- REFERENCES -- Chapter 6: Postpartum Pharmacology -- INTRODUCTION -- PHYSIOLOGY REVIEW: BREAST MILK PRODUCTION AND REGULATION -- DRUG TRANSFER INTO BREAST MILK -- EVALUATING DRUG RISK TO THE INFANT -- CONTEXTUALIZING INFANT RISK MATERNAL DRUGS COMMONLY ASSOCIATED WITH ADVERSE EFFECTS in infants -- STRATEGIES TO REDUCE INFANT RISK -- RESOURCES FOR EVALUATING INFORMATION -- SHARED DECISION-MAKING -- CONCLUSIONS -- LEARNING TOOLS AND RESOURCES -- REFERENCES -- Chapter 7: Common Medications Prescribed in the Newborn Nursery -- INTRODUCTION -- PREVENTION OF OPHTHALMIA NEONATORUM AND VITAMIN K DEFICIENCY BLEEDING -- SPECIAL CIRCUMSTANCES WARRANTING PHARMACOLOGIC TREATMENT -- CONCLUSIONS -- LEARNING TOOLS AND RESOURCES -- REFERENCES -- Chapter 8: Vaccines and Schedules -- INTRODUCTION -- BASIC IMMUNOLOGY PRINCIPLES